Skip to content
Review Open access

The Role of Olfactory Testing in Detecting Prodromal Phase Parkinson’s Disease: A Literature Review

Aug 2026 · Lumina · Vol 2, pp. 32-38 · 0 citations · 9 references

TL;DR

Brief olfactory assessments, particularly those tailored to regional and cultural settings, serve as highly effective, cost-efficient, and non-invasive screening instruments for prodromal PD detection within routine neurogeriatric clinical practice.

Abstract

Introduction: Parkinson's disease (PD) is a progressive neurodegenerative disorder traditionally diagnosed based on classic motor symptoms. However, these motor manifestations appear only after a substantial loss of dopaminergic neurons in the substantia nigra. Detecting PD during its prodromal phase offers a crucial therapeutic window to potentially delay disease progression. Hyposmia is one of the earliest and most prevalent non-motor markers, appearing up to a decade before motor onset. Methods: A comprehensive literature search was conducted across electronic databases, including PubMed, Cochrane Library, and Google Scholar. The inclusion criteria were restricted to original research articles published within the last five years (2021–2026) in English or Indonesian. Data regarding olfactory testing accuracy and cultural adaptation were synthesized. Results: Standardized olfactory assessment tools, such as the University of Pennsylvania Smell Identification Test (UPSIT), Sniffin' Sticks, and the Brief Smell Identification Test (B-SIT), demonstrate high sensitivity (79%) and specificity (81%) in distinguishing PD from diagnostic mimics. Nevertheless, international screening tools frequently suffer from cross-cultural bias due to unfamiliarity with Western odorants. Emerging evidence indicates that adapting these instruments using locally familiar Asian and Indonesian olfactory stimuli (e.g., coffee, jasmine, aromatic ginger, and cajuput oil) significantly optimizes diagnostic accuracy. Conclusions: Brief olfactory assessments, particularly those tailored to regional and cultural settings, serve as highly effective, cost-efficient, and non-invasive screening instruments for prodromal PD detection within routine neurogeriatric clinical practice. Keywords: Parkinson's Disease, Olfactory Testing, Hyposmia, Prodromal Phase, Cross-Cultural Adaptation

Read PDF

Similar papers

Review Open access Sep 2026

Rab proteins as diagnostic biomarkers for Parkinson’s disease: a systematic review

Purpose: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a progressive loss of dopaminergic neurons. PD is typically diagnosed at late-stage, concurrent with loss of up to 70% of these neurons so patient care could be improved by diagnosis at prodromal stages. The occurrence of Parkinsonian-li...

A. Ravinther, H. Dewadas, Rui-Jia Hou et al. · 0 citations
Open access Oct 2026

Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker-Positive, Sporadic Parkinson's Disease.

BACKGROUND Parkinson's disease (PD) is frequently accompanied by neuropsychiatric symptoms (NPS), including cognitive impairment, which often emerge early and co-occur. Their long-term evolution remains incompletely characterized, particularly in biomarker-positive cohorts. OBJECTIVE The aim was to examine the evolut...

Izabelle Schoen, Jing Wang, Sharon X. Xie et al. · 0 citations
Open access Sep 2026

Olfactory impairment and probable REM sleep behavior disorder in Parkinson’s disease: clinical relevance to the single- and dual-hit hypotheses

Conurrent assessment of olfaction and pRBD may improve clinical phenotyping, but longitudinal validation is required; concurrent assessment of olfaction and pRBD may improve clinical phenotyping, but longitudinal validation is required.

Chia-Yen Lin, Ting-Hsin Chang, Ling-Yu Lin et al. · 0 citations
Review Sep 2026

Parkinson's disease diagnosis using machine learning and multimodal biomarkers: A systematic review.

Multimodal fusion architectures, particularly cross-attention transformers integrating motor, voice, and gait data, consistently outperformed unimodal approaches by 4%-8% in the area under the receiver operating characteristic curve (AUC), with the largest gains in early stage detection and differential diagnosis tasks...

Muhammad Imran Khan, A. Imran, A. Alshammari · 0 citations
Review Open access Aug 2026

Young-onset Parkinsonʼs disease: a contemporary view of the problem

Background. Young-onset Parkinsonʼs disease (YOPD) is considered a clinically and genetically heterogeneous form of neurodegenerative pathology characterized by disease onset before the age of 50 years. Despite lower prevalence compared with classical Parkinsonʼs disease, YOPD is associated with substantial medical and...

I. Chernenko, Roman Chernenko · 0 citations
Open access Sep 2026

Early Detection of Parkinson’s Disease Using Parametric Features and Advanced fMRI Analysis

Results demonstrate the effectiveness of the preprocessing strategy and its potential as a non-invasive biomarker for early PD detection, even with reduced input data, and suggest that high classification performance can be achieved with a limited number of fMRI slices, facilitating data acquisition and reducing subjec...

Veronica Hernandez-Ramirez, D. Almanza-Ojeda, Oscar Almanza-Conejo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.